CD68 and amyotrophic lateral sclerosis: The most notable change identified was an increase in CD68, evidenced by increased tissue-wide CD68 average intensity and percentage of CD68high microglia in the human ALS motor cortex, and increased percentage of CD68high microglia in the rNLS mouse motor cortex and hippocampus at early and late disease stages.